Enzalutamide

Chemical formula: C₂₁H₁₆F₄N₄O₂S  Molecular mass: 464.436 g/mol  PubChem compound: 15951529

Therapeutic indications

Enzalutamide is indicated for:

Castration-resistant prostate cancer (CRPC)

Population group: men, only adults (18 years old or older)

Enzalutamide is indicated for:

  • the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (CRPC).
  • the treatment of adult men with metastatic CRPC who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated.
  • the treatment of adult men with metastatic CRPC whose disease has progressed on or after docetaxel therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Enzalutamide is contraindicated in the following cases:

Pregnancy

Pregnancy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: XTANDI Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈